VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
TRV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
TRVThe Travelers Companies, Inc.
$364.51$76.0B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTRVBalance Sheet

The Travelers Companies, Inc. (TRV) Balance Sheet

30Y historyFree accessUpdated daily

Equity has grown 32% from $25.0B in 2024Q1 to $33.1B in 2026Q2, while liabilities grew only 5%, strengthening the capital buffer and supporting a debt-to-equity ratio of 0.27.

TRV Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Assets143.58B143.71B133.19B125.98B115.72B120.47B116.76B110.12B104.23B103.48B100.25B100.18B103.08B103.81B104.94B104.58B105.66B109.56B109.63B115.22B115.29B113.19B111.25B64.87B39.96B38.32B35.5B38.87B38.32B37.36B20.68B
Asset Growth %22.7%7.9%5.72%8.87%-3.94%3.17%6.03%5.65%0.72%3.23%0.06%-2.81%-0.71%-1.07%0.35%-1.02%-3.56%-0.07%-4.85%-0.06%1.86%1.74%71.49%62.35%4.27%7.94%-8.67%1.44%2.58%80.64%5.21%
Total Investment Assets4M101.18B94.22B88.81B80.45B87.38B84.42B77.88B72.28B72.5B70.49B70.47B73.26B73.16B73.84B72.7B72.72B74.97B70.74B75.67B72.27B68.29B64.37B38.65B22.73B22.18B22.05B22.32B23.3B13.93B13.04B
Long-Term Investments184.99B75.72B5.1B05.02B4.84B80B73.5B67.82B68.04B66.11B66.03B68.74B68.78B69.52B68.39B68.95B71.15B66.88B70.59B68.08B64.36B59.97B35.92B2.55B3.56B3.8B22.32B21.93B13.93B13.04B
Short-Term Investments4.58B25.46B89.12B88.81B75.44B82.54B79.51B73.08B67.45B67.59B65.38B65.33B67.84B67.84B68.88B67.83B5.62B4.85B5.22B5.19B4.94B4.8B4.94B2.14B2.15B2.15B2.33B1.37B982.49M441.36M289.79M
Total Current Assets20.66B50.35B114.05B116.28B98.47B105.24B0000000000000000000000000
Cash & Equivalents621M710M568M650M799M761M721M494M373M344M307M380M374M294M330M214M200M255M350M271M459M337M262M352M315M151M52M165M119.84M22.66M37.21M
Receivables85.28B22.77B23.03B10.97B21.21B21.04B20.42B20.74B20.66B20.23B19.62B19.72B19.92B20.17B21.39B22.07B10.84B11.27B12.19B12.84B12.73B11.64B11.83B7.21B3.18B3.63B3.4B2.92B2.63B2.21B1.56B
Other Current Assets0132M131M15.85B00-101.43B-95B-89.06B-88.71B-85.89B-86.09B-88.81B-89.1B-91.45B-90.94B-16.66B-16.38B-17.76B-18.3B-18.13B-16.78B-17.04B-9.7B-5.64B-5.93B-5.78B-4.46B-3.73B-2.68B-1.89B
Goodwill & Intangibles28.59B7.92B8.09B4.25B7.08B6.86B4.29B4.29B4.28B4.29B3.85B3.85B3.92B3.98B3.75B3.8B3.87B3.95B4.05B4.18B4.2B4.36B4.63B2.83B1.01B690M510M509M592.06M618.5M167.3M
Goodwill4.06B4.07B4.23B3.98B3.95B4.01B3.98B3.96B3.94B3.95B3.58B3.57B3.61B3.63B3.37B3.37B3.37B3.37B3.37B3.37B3.44B3.44B3.56B2.41B874M3.63B510M509M592.06M00
Intangible Assets325M3.85B3.85B277M3.12B2.85B317M330M345M342M268M279M304M351M381M433M502M588M688M814M764M917M1.06B422M139M0000618.5M167.3M
PP&E (Net)00000000000000000000000343M459M486M492M507M518.5M602.4M281.1M
Other Assets18.9B8.83B4.18B3.94B3.27B3.53B-84.29B-77.79B-72.1B-72.33B-69.96B-69.89B-72.65B-72.77B-73.27B-72.18B-72.82B-75.1B-70.93B-74.77B-72.28B-68.72B-64.6B-39.09B-4.02B-4.74B-4.8B-23.34B-23.04B-15.15B-13.49B
Total Liabilities110.46B110.81B105.33B101.06B94.16B91.58B87.56B84.18B81.34B79.75B77.02B76.59B78.24B79.02B79.53B80.1B80.18B82.14B84.31B88.61B90.16B90.88B90.05B52.88B34.21B33.21B28.27B31.98B31.18B30.25B16.47B
Total Debt9.07B9.27B8.03B8.03B7.29B7.29B6.55B6.56B6.56B6.57B6.44B6.34B6.35B6.35B6.35B6.61B6.61B6.53B6.18B5.58B5.76B5.85B6.31B2.67B2.71B2.13B1.65B1.47B1.26B1.3B689.1M
Net Debt8.45B8.56B7.46B7.38B6.49B6.53B5.83B6.06B6.19B6.23B6.13B5.96B5.97B6.05B6.02B6.39B6.41B6.27B5.83B5.31B5.3B5.51B6.05B2.32B2.4B1.98B1.59B1.3B1.14B1.28B651.89M
Long-Term Debt9.07B8.97B7.93B7.93B7.19B7.19B6.45B5.96B5.96B5.97B5.89B5.84B5.85B6.25B5.75B6.25B6.5B6.15B5.94B4.93B5.76B5.85B6.31B2.67B2.71B2.13B1.65B1.47B1.26B1.3B689.1M
Short-Term Debt0300M100M100M100M100M100M600M600M600M550M500M500M100M600M350M109M373M242M649M00000000000
Total Current Liabilities101.39B92.02B90.22B82.5B81B78.06B4.62B05.67B5.65B5.43B5.17B5.2B4.73B5.75B5.92B516M919M770M1.27B685M720M896M1.44B1.97B1.98B2.09B1.81B2.9B0665.59M
Accounts Payable3.09B3.56B3.74B3.79B4.01B4.29B4.62B4.98B5.07B5.05B4.88B4.67B4.7B4.63B5.15B5.58B407M546M528M618M685M720M896M403M1.01B943M1.06B1.81B2.9B0665.59M
Deferred Revenue23.33B22.43B22.29B20.87B18.24B16.47B0000000000000000000000000
Other Current Liabilities73.96B65.74B64.09B57.66B58.65B57.2B-100M-5.58B00000000000000000000000
Deferred Taxes000001000K1000K1000K0000001000K0000000000000000
Other Liabilities09.82B7.17B10.63B5.96B6.04B75.84B-6.09B69.7B68.13B65.7B65.57B67.19B68.04B67.69B67.92B73.16B75.07B77.6B82.41B83.71B84.31B82.84B48.77B29.53B29.1B24.54B28.7B27.03B28.94B15.12B
Total Equity33.12B32.89B27.86B24.92B21.56B28.89B29.2B25.94B22.89B23.73B23.22B23.6B24.84B24.8B25.41B24.48B25.48B27.41B25.32B26.62B25.14B22.3B21.2B11.99B5.75B5.11B7.56B6.9B7.14B7.11B4.21B
Equity Growth %57.85%18.05%11.81%15.59%-25.36%-1.08%12.56%13.32%-3.53%2.2%-1.6%-4.98%0.16%-2.4%3.79%-3.92%-7.08%8.28%-4.87%5.89%12.7%5.2%76.87%108.61%12.36%-32.39%9.67%-3.39%0.4%68.87%12.89%
Shareholders Equity33.12B32.89B27.86B24.92B21.56B28.89B29.2B25.94B22.89B23.73B23.22B23.6B24.84B24.8B25.41B24.48B25.48B27.41B25.32B26.62B25.14B22.3B21.2B11.99B5.75B5.11B7.23B6.47B6.64B6.61B4B
Minority Interest00000000000000000000000000337M425M502.7M502.7M207M
Retained Earnings58.35B54.93B49.63B45.59B43.52B41.55B38.77B36.98B35.2B33.46B32.2B29.95B27.25B24.29B21.35B19.58B18.85B16.32B13.31B11.11B7.25B3.75B2.74B2.29B2.47B2.5B4.24B3.83B3.48B3.72B2.94B
Common Stock26.19B25.91B25.45B24.91B24.57B24.15B23.74B23.47B23.14B22.89B22.61B22.17B21.84B21.5B21.16B20.73B00018.99B00000002.08B2.13B512.16M475.71M
Accumulated OCI-2.67B-2.5B-4.97B-4.47B-6.45B1.19B2.5B640M-1.86B-343M-755M-157M880M810M2.24B2B1.25B1.22B-900M670M452M351M952M1.09B602M364M697M542M1.01B655.67M596.47M
Return on Equity (ROE)25.62%20.7%18.94%12.87%11.27%12.61%9.78%10.74%10.82%8.76%12.88%14.2%14.88%14.63%9.92%5.71%12.16%13.74%11.26%17.78%17.74%7.46%5.76%19.13%-0.5%-17.16%13.73%11.88%1.25%16.41%18.45%
Return on Assets (ROA)5.79%4.54%3.86%2.48%2.41%3.09%2.38%2.45%2.43%2.02%3.01%3.38%3.57%3.52%2.36%1.36%2.99%3.3%2.6%3.99%3.68%1.45%1.08%3.24%-0.07%-2.95%2.67%2.16%0.24%3.2%3.63%
Equity / Assets23.07%22.89%20.92%19.78%18.63%23.98%25.01%23.56%21.96%22.93%23.16%23.55%24.09%23.89%24.21%23.41%24.11%25.02%23.09%23.1%21.8%19.7%19.06%18.48%14.38%13.35%21.31%17.74%18.63%19.03%20.36%
Debt / Equity0.27x0.28x0.29x0.32x0.34x0.25x0.22x0.25x0.29x0.28x0.28x0.27x0.26x0.26x0.25x0.27x0.26x0.24x0.24x0.21x0.23x0.26x0.30x0.22x0.47x0.42x0.22x0.21x0.18x0.18x0.16x
Book Value per Share155.06144.53120.57107.3389.95115.18114.6998.9184.8685.1879.8075.1872.5166.2565.1758.2152.8047.4741.9039.8135.0731.2933.7426.4424.6124.1232.4628.0428.2640.2222.37
Tangible BV per Share134.53109.7385.5889.0160.4387.8497.8382.5568.9869.7766.5762.9161.0855.6055.5649.1844.7840.6335.1933.5629.2125.1726.3820.1920.277.0030.2725.9725.9136.7221.48

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Reserve adequacy under social inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Capital Base Expanding Steadily

According to SEC filings, Travelers' equity grew from $25.0B in 2024Q1 to $33.1B in 2026Q2, a 32% increase, while total assets rose to $143.6B, indicating sustained capital generation.

The balance sheet is clearly strengthening, with equity expanding by roughly $8.1B over the ten-quarter period. This growth is supported by strong underwriting profitability, as evidenced by the combined ratio improving to 76.3% in 2026Q2 from 87.8% in 2024Q1. The consistent rise in equity, despite quarterly fluctuations, suggests robust internal capital generation and a solid foundation for future growth.

Investment Portfolio Yield Opaque

Investment income and yield data are unavailable for all quarters, but total invested assets are reported at $1,000.0K, which appears inconsistent with the scale of the balance sheet, warranting further investigation.

The reported invested asset figure of $1,000.0K is implausibly low for a company with $143.6B in total assets, suggesting a data reporting issue. Given the lack of reliable investment income data, the contribution of the investment portfolio to overall profitability remains unclear. Investors should monitor the fixed income allocation and duration, as these are critical for matching long-duration liabilities.

Reserve Releases Bolster Results

As reported in financial statements, loss ratios improved from 82.8% in 2025Q1 to 63.4% in 2026Q2, a 19.4 percentage point drop, suggesting favorable prior-year reserve development may be inflating current underwriting results.

The sharp improvement in loss ratios, despite stable claims payments, indicates that reserve releases are likely contributing to earnings. While this enhances reported profitability, it raises questions about the adequacy of current reserves, especially in the context of social inflation and litigation trends. The elevated loss ratio in 2025Q1 (82.8%) may reflect a trough in reserve adequacy, and the subsequent improvement could be partly due to favorable development rather than underlying loss experience.

Equity Growth Supports Solvency

Based on reported figures, Travelers' equity increased from $27.9B in 2024Q4 to $33.1B in 2026Q2, a 19% rise, while liabilities grew only 5%, indicating a strengthening capital buffer.

The equity growth outpacing liability growth suggests an improving solvency position. The debt-to-equity ratio, though not directly provided, appears manageable given the equity expansion. This capital strength provides capacity for shareholder returns and potential M&A, as evidenced by the escalating dividends and buybacks noted in the cash flow analysis.

Claims-Paying Ability Intact

Claims and loss payments declined from $9.8B in 2025Q1 to $7.7B in 2026Q2, a 21% reduction, per SEC filings, while cash and invested assets remain substantial, supporting near-term liquidity.

The reduction in claims payments, combined with stable operating cash flow, suggests that Travelers maintains adequate liquidity to meet policyholder obligations. However, the lack of explicit cash balance data limits a full assessment of the claims-paying liquidity profile. The company's ability to generate operating cash flow consistently above net income in most quarters indicates a strong cash conversion, which is critical for an insurer.

Reserve Adequacy Under Social Inflation

The sharp loss ratio improvement may be partly due to favorable reserve development, but social inflation and litigation trends could pressure future reserves, as indicated by 2025Q1's elevated loss ratio.

The most non-obvious risk is the potential inadequacy of loss reserves in the face of social inflation. The 2025Q1 loss ratio of 82.8% suggests a period of adverse development, and the subsequent improvement may not be sustainable. If reserve releases are masking underlying deterioration, future earnings could be negatively impacted. Investors should monitor reserve development disclosures and the impact of litigation trends on long-tail lines.

TRV — Frequently Asked Questions

Quick answers to the most common questions about buying TRV stock.

What are the total assets of The Travelers Companies, Inc. (TRV)?

As of 2025, The Travelers Companies, Inc. (TRV) had total assets of $143.71B including $50.35B in current assets.

How much debt does The Travelers Companies, Inc. (TRV) have?

The Travelers Companies, Inc. (TRV) carries total debt of $9.27B, offset by $26.17B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of The Travelers Companies, Inc.?

The Travelers Companies, Inc. (TRV) has total shareholders' equity (book value) of $32.89B ($144.53 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is The Travelers Companies, Inc.'s current ratio and liquidity?

The Travelers Companies, Inc. (TRV) reported a current ratio of 0.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.